Portage Biotech (PRTG)
(Delayed Data from NSDQ)
$9.30 USD
-0.67 (-6.72%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $9.67 +0.37 (3.98%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Portage Biotech Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PRTG 9.30 -0.67(-6.72%)
Will PRTG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PRTG based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PRTG
Portage Biotech Reports Improved Fiscal Year Results
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025 | PRTG Stock News
Portage Biotech Inc. Enters ATM Agreement with Rodman & Renshaw
Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Wednesday's Pre-Market Session